Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

PENICILLIN IN THE ORAL THERAPY OF VINCENT'S ANGINA AND ACUTE FOLLICULAR TONSILLITIS

PENICILLIN IN THE ORAL THERAPY OF VINCENT'S ANGINA AND ACUTE FOLLICULAR TONSILLITIS Abstract THIS preliminary report is not intended as a completely scientific study of a problem about which much is still being written but rather as an attempt from an overseas theater to add some material for the evaluation of penicillin as used in the oral therapy of tonsillar infections. Only two conditions will be dealt with in this report: Vincent's angina and acute follicular tonsillitis. There is still much discussion as to the etiologic nature of Vincent's angina, and poor oral hygiene, local irritation, debilitating disease and other conditions have been called predisposing factors. The question has been raised as to whether the spirochetes and the fusiform bacilli of Vincent may not be pleomorphic forms of the same organism. However that may be, the manner in which lesions showing the presence of these organisms respond to treatment with penicillin can leave little doubt that Vincent's organisms are certainly associated with the References 1. MacGregor, A. B., and Long, D. A.: The Use of Penicillin Pastilles in Oral Infections , Brit. M. J. 2:686 ( (Nov. 25) ) 1944.Crossref 2. Nipagin is produced by the Goldschmidt Chemical Corporation, New York. 3. Bigger, J. W.: Synergic Action of Penicillin and Sulfonamides , Lancet 2:142 ( (July 29) ) 1944.Crossref 4. Ungar, J.: Synergistic Effect of Paraminobenzoic Acid and Sulfapyridine on Penicillin , Nature , London 152:245 ( (Aug. 28) ) 1943.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Otolaryngology American Medical Association

PENICILLIN IN THE ORAL THERAPY OF VINCENT'S ANGINA AND ACUTE FOLLICULAR TONSILLITIS

Archives of Otolaryngology , Volume 44 (4) – Oct 1, 1946

Loading next page...
 
/lp/american-medical-association/penicillin-in-the-oral-therapy-of-vincent-s-angina-and-acute-x56vPGyUHJ
Publisher
American Medical Association
Copyright
Copyright © 1946 American Medical Association. All Rights Reserved.
ISSN
0003-9977
DOI
10.1001/archotol.1946.00680060430005
Publisher site
See Article on Publisher Site

Abstract

Abstract THIS preliminary report is not intended as a completely scientific study of a problem about which much is still being written but rather as an attempt from an overseas theater to add some material for the evaluation of penicillin as used in the oral therapy of tonsillar infections. Only two conditions will be dealt with in this report: Vincent's angina and acute follicular tonsillitis. There is still much discussion as to the etiologic nature of Vincent's angina, and poor oral hygiene, local irritation, debilitating disease and other conditions have been called predisposing factors. The question has been raised as to whether the spirochetes and the fusiform bacilli of Vincent may not be pleomorphic forms of the same organism. However that may be, the manner in which lesions showing the presence of these organisms respond to treatment with penicillin can leave little doubt that Vincent's organisms are certainly associated with the References 1. MacGregor, A. B., and Long, D. A.: The Use of Penicillin Pastilles in Oral Infections , Brit. M. J. 2:686 ( (Nov. 25) ) 1944.Crossref 2. Nipagin is produced by the Goldschmidt Chemical Corporation, New York. 3. Bigger, J. W.: Synergic Action of Penicillin and Sulfonamides , Lancet 2:142 ( (July 29) ) 1944.Crossref 4. Ungar, J.: Synergistic Effect of Paraminobenzoic Acid and Sulfapyridine on Penicillin , Nature , London 152:245 ( (Aug. 28) ) 1943.Crossref

Journal

Archives of OtolaryngologyAmerican Medical Association

Published: Oct 1, 1946

References